Published peptide research references
Albiglutide
Governed registry record
4 approved source records with original-source links. Source verification confirms the reference and its connection to this record; it does not certify every scientific conclusion or establish safety or efficacy.
Approved source records
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial.
DOI: 10.1016/s0140-6736(18)32261-x
Source identity and connection checked by Codex (AI).
Cardiovascular Effects and Tolerability of GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis of 99,599 Patients.
DOI: 10.1016/j.jacc.2025.08.027PMID: 40892610
Source identity and connection checked by Codex (AI).
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials.
DOI: 10.1016/s2213-8587(19)30249-9PMID: 31422062
Source identity and connection checked by Codex (AI).
GLP-1 receptor agonists in the treatment of type 2 diabetes - state-of-the-art.
DOI: 10.1016/j.molmet.2020.101102PMID: 33068776
Source identity and connection checked by Codex (AI).
Legacy research context
Context from the legacy curated dataset. Its counts describe that dataset and are separate from the live approved source records above.
Researchers represented
- Hernandez AF
- Green JB
- Janmohamed S
- D'Agostino RB Sr
- Granger CB
- Jones NP
- Leiter LA
- Rosenberg AE
- Sigmon KN
- Somerville MC
- Thorpe KM
- McMurray JJV
- Del Prato S
- Harmony Outcomes committees and investigators
- Nauck MA
- Quast DR
- Wefers J
- Meier JJ
- Kristensen SL
- Rørth R
- Jhund PS
- Docherty KF
- Sattar N
- Preiss D
- Køber L
- Petrie MC
- Galli M
- Benenati S
- Laudani C
- Simeone B
- Sarto G
- Ortega-Paz L
- Rocco E
- Bernardi M
- Spadafora L
- D'Amario D
- Greco E
- Frati G
- Federici M
- Mehran R
- Crea F
- Angiolillo DJ
- Sciarretta S